- Home
- / SB-Kawasumi Laboratories
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
SB-Kawasumi Laboratories financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
¥22.3 B
FY, 2020
CreditSafe Score
?
Score changed on Jun 10, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| JPY | FY, 2018 | FY, 2019 | FY, 2020 |
|---|---|---|---|
| Revenue | 25.4B | 24.1B | 22.3B |
| Cost of goods sold | 15.1B | 14.3B | 13.2B |
| Gross profit | 10.4B | 9.8B | 9.1B |
| Gross profit margin, % | 40.8% | 40.8% | 40.8% |
| Operating expense total | 8.0B | 7.6B | 6.9B |
| Depreciation and amortization | 1.7B | 1.6B | 1.6B |
| EBITDA | 2.4B | 2.2B | 2.2B |
| EBITDA margin, % | 9.4% | 9.3% | 9.9% |
| EBIT | 640.0M | (1.0B) | 751.0M |
| EBIT margin, % | 2.5% | -4.3% | 3.4% |
| Interest income | 40.0M | 49.0M | 44.0M |
| Interest expense | 1.0M | 1.0M | 1.0M |
| Pre tax profit | 733.0M | 409.0M | 1.9B |
| Income tax expense | 284.0M | 221.0M | 541.0M |
| Net Income | 449.0M | 188.0M | 1.4B |